When was Kailos founded?

Kailos was founded in 2010 and raised its 1st funding round 1 year after it was founded.

Where is Kailos located?

Kailos is headquartered in Huntsville, United States. It is registered at Huntsville, Alabama.

How many employees does Kailos have?

As of Sep 30, 2026, the latest employee count at Kailos is 19.

Is Kailos a funded company?

Kailos is a funded company, having raised a total of $3.9M across 4 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Dec 16, 2011.

When was the latest funding round of Kailos?

Kailos' latest funding was a $***** Series B round on Apr 22, 2022, with participation from 0 investor. Its primary sector is Healthcare Booking Platforms. In United States, the Healthcare Booking Platforms sector has seen $2.17B in funding in 2026 to date.

Where does Kailos rank among its competitors?

Kailos ranks 11th amongst 77 active competitors, of which 14 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was GreenLight Biosciences, which secured $25M in Apr, 2025.

Who are the top competitors of Kailos?

Kailos' top competitors include Helix, Color and Veritas Genetics. Among them, GreenLight Biosciences secured the most recent funding round in April, 2025.

Kailos - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of consumer-based genetic testing services. The company leverages clinical-grade assays, next-generation sequencing, and powerful analytics to bring actionable genetic information and offers cancer testing, pharmacogenetic testing, and research services.

Website: kailosgenetics.com
Social
Email ID: *****@kailosgenetics.com
Registered Address: Huntsville, Alabama

Key Metrics

Founded Year

2010

Location

Huntsville, United States

Stage

Acquired

Total Funding

$3.9M in 4 rounds

Latest Funding Round

Series B, Apr 22, 2022, $*****

Investors

In-Q-Tel & 2 more

Ranked

11^th among 77 active competitors

Employee Count

19 as on Sep 30, 2026

Similar Companies

MyHeritage & 299 more

Exit Details

Acquired by HealthOme (Jun 01, 2023)

View Kailos' full profile

Kailos is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Kailos Genetics, Inc. CIN: 272273256 , United States, Active	Mar 31, 2010	-	10 (As on Dec 31, 2023)	-

Kailos got acquired by HealthOme on Jun 01, 2023.

Click here to take a look at Kailos's acquisition in detail

Kailos has raised a total funding of $3.9M over 4 rounds. Its first funding round was on Dec 16, 2011. Kailos has 3 institutional investors.

Here is the list of recent funding rounds of Kailos:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 22, 2022	3975268	Series B	8087051	2166511	9090842	5834069
Jul 11, 2017	6816507	Series B	6300132	4871313	5419472	In-Q-Tel
Jun 22, 2016	2717956	Grant (prize money)	9570594	8161683	3871181	NIH

Access funding benchmarks and valuations. Sign up today!

View details of Kailos's funding rounds and investors

The founders of Kailos is Brian Pollock.

Here are the details of Kailos' key team members:

Brian Pollock: Co-Founder & CEO of Kailos.

View details of Kailos's Founder profiles and Board Members

Kailos' employee count trend

Kailos has 19 employees as of Sep 26. Here is Kailos's employee count trend over the years:

Uncover Kailos' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Kailos include Helix, Color and Veritas Genetics. Here is the list of Top 10 competitors of Kailos, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Helix 2015, San Francisco (United States), Series E	Provider of a genomic database for clinical research	$435M	DFJ Growth, Kleiner Perkins & 13 others	73/100
2nd	Color 2013, Burlingame (United States), Series E	Provider of end-to-end Virtual clinic offering cancer-based solutions	$491M	General Catalyst, T. Rowe Price & 47 others	61/100
3rd	Veritas Genetics 2014, Danvers (United States), Acquired	Provider of genetic testing products	$53.4M	Trustbridge Partners, Simcere Pharma & 6 others	57/100
4th	Counsyl 2007, San Francisco (United States), Acquired	DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening	$113M	Perceptive Advisors, Goldman Sachs & 14 others	57/100
5th	GreenLight Biosciences 2008, Lexington (United States), Public	Developer of a platform for RNA-based products for life science industry	$225M	Baird Capital, Kodiak Venture Partners & 36 others	52/100
6th	ARCpoint Labs 2005, Greenville (United States), Public	Provider of genetic testing services	-	-	51/100
7th	Recombine 2011, New York City (United States), Acquired	Genetic testing services	$12.1M	FirstMark, Vast Ventures & 3 others	48/100
8th	SelfDecode 2016, San Luis Obispo (United States), Series A	Provider of personal genome analysis service	$8M	BoxOne Ventures & 2 others	47/100
9th	Digbi Health 2018, Mountain View (United States), Series A	Provider of personalized healthcare on basis of DNA testing	$8.5M	Accel, Seraph Group & 9 others	46/100
10th	Arivale 2014, Seattle (United States), Series C	Provider of direct-to-consumer genetic testing.	$53.6M	Maveron, New York Life Ventures & 4 others	44/100
11th	Kailos 2010, Huntsville (United States), Acquired	Provider of consumer-based genetic testing services	$3.9M	In-Q-Tel, New Capital Partners & 1 others	43/100